| 查看: 1158 | 回复: 1 | |||
[交流]
李红良教授《去泛素化酶TNFAIP3通过抑制肝脏ASK1活性缓解非酒精性脂肪肝炎》
|
|
国是世界肝病大国，全国超过3亿人存在不同程度的非酒精性脂肪肝，可进一步发展为肝硬化，甚至肝癌、肝衰竭，同时增加多种心脑血管和代谢性疾病患病风险。然而，国际上尚无针对非酒精性脂肪肝的临床用药。肝脏切除和肝脏移植成为治疗晚期肝病的主要手段，但手术过程中不可避免的肝脏缺血再灌注损伤极大限制了肝脏手术的开展和救治效果。 本次发表的两篇论文中，“The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis”（《去泛素化酶TNFAIP3通过抑制肝脏ASK1活性缓解非酒精性脂肪肝炎》）阐释了一条新的非酒精性脂肪肝病发展内在的抑制途径。博士后张鹏、王丕晓、博士生赵玲萍为共同第一作者，李红良和折志刚教授为共同通讯作者。（论文链接：https://www.nature.com/articles/nm.4453） Activation of apoptosis signal-regulating kinase 1 (ASK1) in hepatocytes is a key process in the progression of nonalcoholic steatohepatitis (NASH) and a promising target for treatment of the condition. However, the mechanism underlying ASK1 activation is still unclear, and thus the endogenous regulators of this kinase remain open to be exploited as potential therapeutic targets. In screening for proteins that interact with ASK1 in the context of NASH, we identified the deubiquitinase tumor necrosis factor alpha–induced protein 3 (TNFAIP3) as a key endogenous suppressor of ASK1 activation, and we found that TNFAIP3 directly interacts with and deubiquitinates ASK1 in hepatocytes. Hepatocyte-specific ablation of Tnfaip3 exacerbated nonalcoholic fatty liver disease– and NASH-related phenotypes in mice, including glucose metabolism disorders, lipid accumulation and enhanced inflammation, in an ASK1-dependent manner. In contrast, transgenic or adeno-associated virus–mediated TNFAIP3 gene delivery in the liver in both mouse and nonhuman primate models of NASH substantially blocked the onset and progression of the disease. These results implicate TNFAIP3 as a functionally important endogenous suppressor of ASK1 hyperactivation in the pathogenesis of NASH and identify it as a potential new molecular target for NASH therapy.  |
回复此楼» 猜你喜欢
我要收集念力为面上祈福
已经有124人回复
-
北欧招聘博士后 | 纳米药物/药物递送
已经有6人回复
-
急重症医学/创伤/烧伤/整形论文润色/翻译怎么收费?
已经有290人回复
-
生物化学蛋白表达专业方向申博自荐
已经有8人回复
-
有偿求hindawi的版面费优惠券
已经有0人回复
-
[JoVE] Special Issues 邀稿
已经有0人回复
-
纳米药物/药物递送/高分子化学/有机化学/免疫细胞生物学 | 芬兰招聘24年博士后
已经有5人回复
-
药物递送/纳米药物/生物材料/组织工程 | 招聘24年攻博生
已经有1人回复
-
求购elsevier 版面费优惠码
已经有12人回复
-
生物信息学或者生物相关专业 （学硕）
已经有0人回复
-
2024或2025申博求带走
已经有5人回复
|
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis Peng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, Xin Zhang, Yan-Xiao Ji, Xiao-Jing Zhang, Chun Fang, Yue-Xin Lu, Xia Yang, Mao-Mao Gao, Yan Zhang, Song Tian, Xue-Yong Zhu, Jun Gong, Xin-Liang Ma, Feng Li, Zhihua Wang, Zan Huang, Zhi-Gang She & Hongliang Li |
2楼2018-07-17 21:51:27
30